Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

594
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
594
Schemas01:42

Schemas

12.3K
A schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
12.3K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

16.3K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.3K
pre-mRNA Processing02:01

pre-mRNA Processing

57.5K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesions.

Frontiers in neural circuits·2026
Same author

IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma.

Cancers·2026
Same author

Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.

Journal of neuro-oncology·2026
Same author

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Nature·2026
Same author

Rethinking the role of surgery and radiotherapy in BRAF-mutant papillary craniopharyngioma: a position statement from the neurosurgical perspective.

Neurosurgical focus·2026
Same author

Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.

Neuro-oncology·2026

Related Experiment Video

Updated: Feb 2, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.3K

Updates in prognostic markers for gliomas.

Elisa Aquilanti1,2,3,4, Julie Miller1,5,3, Sandro Santagata6,7,8

  • 1Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Neuro-Oncology
|November 10, 2018
PubMed
Summary

This study analyzes key molecular prognostic factors in adult gliomas, crucial for updated brain tumor classification and patient outcomes. Understanding these genetic markers improves glioma diagnosis and treatment strategies.

More Related Videos

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.6K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.2K

Related Experiment Videos

Last Updated: Feb 2, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.3K
Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.6K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.2K

Area of Science:

  • Neuro-oncology
  • Molecular diagnostics
  • Genomics

Background:

  • Gliomas are primary malignant brain tumors in adults, traditionally classified by histology and grade.
  • Recent advances in molecular diagnostics reveal crucial genomic drivers in gliomagenesis.
  • These molecular markers significantly impact prognosis and have led to revised brain tumor classifications.

Purpose of the Study:

  • To provide a comprehensive analysis of molecular prognostic factors in gliomas.
  • To highlight the integration of molecular markers into updated glioma classification systems.
  • To discuss the prognostic implications of various genetic alterations in brain tumors.

Main Methods:

  • Analysis of established molecular markers including isocitrate dehydrogenase (IDH) mutation, 1p/19q codeletion, and histone mutations.
  • Investigation of additional prognostic factors such as telomerase reverse transcriptase (TERT) promoter mutations.
  • Assessment of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and glioma CpG island methylator phenotype (G-CIMP).

Main Results:

  • Molecular markers like IDH mutations, 1p/19q codeletion, and histone mutations are integral to current glioma classification.
  • Other factors such as TERT promoter mutations and MGMT promoter methylation show significant prognostic value.
  • Epidermal growth factor receptor (EGFR) alterations and G-CIMP status also contribute to understanding glioma behavior.

Conclusions:

  • Molecular profiling is essential for accurate glioma classification and prognostication.
  • Updated classifications incorporating these markers improve diagnostic precision.
  • Further research into these molecular factors will refine treatment strategies for brain tumor patients.